Cardiac amyloidosis and heart failure phenotypes: a prognostic study of systolic function markers

31 August 2025 (17:00 - 17:10)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Assistant Professor Amira Zaroui

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail

The impact of left ventricular reverse remodeling on asymptomatic structual heart disease

Doctor K. Tanaka (Niigata, JP)

Abstract Slides Video

Presentation thumbnail

Proteomic profiling of circulating exosome identifies CAPG as a key molecule associated with clinical outcomes in heart failure

Doctor S. Okochi (Fukushima, JP)

Abstract Slides Video

Presentation thumbnail

Impact of obesity and breathlessness on MACE outcomes within HFpEF: results from the UK Biobank

Doctor M. Mahmod (Oxford, GB)

Abstract Slides Video

Presentation thumbnail

Mismatch between lead I from the 12-Lead ECG and smartwatch ECG: can AI models adapt for left ventricular systolic dysfunction prediction?

Mr J. Jang (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Identification of biomarkers for right ventricular dysfunction in dilated cardiomyopathy using urinary proteomics and machine learning

Doctor J. Zhang (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Mechanisms of heart failure: emerging evidence

The Event

Event poster

ESC Congress 2025

31 August 2025 17:00 CET

You may be interested in

Congress Presentation

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

Congress Session

Echocardiographic monitoring of cardiomyopathies and heart failure

Congress Session

Cardiac amyloidosis from epidemiology to treatment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources